US electroceuticals market is expected to grow at a CAGR of 7.8% during the forecast period. The market growth is attributed to the rise in the prevalence of arrhythmia, growing number of neural disorders, and high prevalence of hearing loss. In addition, rising number of Parkinson’s disease and expected approvals for retinal implants in the US are anticipated to contribute significantly to the growth of electroceuticals market. The US has a high incidence and prevalence rate of heart diseases due to the sedentary lifestyle, excessive consumption of alcohol, consumption of junk food, and huge number of diabetic and obese patients. 

The traumatic brain injury is the most common cause of fatality and disability in the US. As per the report of the Centers for Disease Control and Prevention (CDC), in 2017, 30% of all the injury-related mortalities occurred due to the traumatic brain injury in the US. According to the Center for Medicare and Medicaid Services, in 2017, the US national healthcare expenditure was around $3.5 trillion showing a 3.9% increase in healthcare expenditure. The US has the highest healthcare spending across the globe. In the US, the per capita healthcare expenditure per person in 2017 was around $10,739, as per the CMS. 

The market is segmented on the basis of product and end-user. On the basis of product, the market is segmented into cardioverter defibrillators and cardiac pacemaker, deep brain stimulators (DBS), spinal cord stimulators (SCS), vagus nerve stimulators, hearing aids, and cochlear implants, and others such as sacral nerve stimulators, and transcutaneous electrical nerve stimulators. By end-user segment, the market is segmented into hospitals & clinics and homecare and other. Few players operating in the US electroceuticals market include Medtronic PLC, Abbott Laboratories, Inc., Boston Scientific Corp., LivaNova PLC, Cochlear, Ltd., Sonova Holding AG, Nevro Corp., ElectroCore LLC, and BioElectronics Corp.

Research Methodology

The market study of the US electroceuticals market is incorporated by extensive primary and secondary research conducted by the research team at OMR.  Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report is intended for medical device manufacturing companies, distributors and suppliers, and other related companies for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. The US Electroceuticals Market Research and Analysis by Product 
2. The US Electroceuticals Market Research and Analysis by End-User

The Report Covers

• Comprehensive research methodology of the US electroceuticals market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the US electroceuticals market.
• Insights about market determinants which are stimulating the US electroceuticals market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.